Effect of treating isolated systolic hypertension on the risk of developing of stroke: The systolic hypertension in the elderly program (SHEP)

JAMA

Volumn 284, Issue 4, 2000, Pages 465-471

  Perry, H Mitchell ^a,b   Davis, Barry R ^c   Price, Thomas R ^d   Applegate, William B ^e   Fields, William S ^c   Guralnik, Jack M ^f   Kuller, Lewis ^g   Pressel, Sara ^c   Stamler, Jeremiah ^h   Probstfield, Jeffrey L ⁱ  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CHLORTALIDONE; PLACEBO; RESERPINE;

ADULT; AGING; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME;

EID: 0343081034     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.4.465     Document Type: Article

References (21)

1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
2. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J Clin Epidemiol. 1988;41:1197-1208.
3. Borhani NO, Applegate WB, Cutler JA, et al. Systolic Hypertension in the Elderly Program (SHEP), part 1: rationale and design. Hypertension. 1991;17:112-115.
4. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods and baseline characteristics. Stroke. 1988;19:547-554.
5. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304-1305.
6. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md Med J. 1965;14:61-65.
7. Weiler PG, Camel GH, Chiappini M, et al. Systolic Hypertension in the Elderly Program (SHEP), part 9: behavioral characteristics. Hypertension. 1991;17: 152-161.
8. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
9. Moreau T, O'Quigley J, Lellouch J, On D. Schoenfeld's approach for testing the proportional hazards assumption. Biometrika. 1986;73:513-515.
10. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
11. Snedecor CW, Cochran WG. Statistical Methods. Ames: Iowa State University Press; 1980.
12. Cole FM, Yates PO. Comparative incidence of cerebrovascular lesions in normotensive and hypertensive patients. Neurology. 1968;18:255-259.
13. Ross-Russell RW. How does blood pressure cause stroke? Lancet. 1975;2:1283-1285.
14. Fisher CM. Lacunar strokes and infarcts: a review. Neurology. 1982;32:871-876.
15. Spence JD. Antihypertensive drugs and prevention of atherosclerotic stroke. Stroke. 1986;17:808-810.
16. Furlan AJ, Whisnant JP, Elveback LR. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol. 1979;5:367-373.
17. Baker AB, Resch JA, Loewenson RB. Hypertension and cerebral atherosclerosis. Circulation. 1969; 39:701-710.
18. Inzitari D, Bianchi F, Pracucci G. et al. The Italian Multicenter Study of Reversible Cerebral Ischemic Attacks, IV: blood pressure components and atherosclerotic lesions. Stroke. 1986;17:185-192.
19. Anim JI, Kofi AD. Hypertension, cerebral vascular changes and stroke in Ghana: cerebral atherosclerosis and stroke. East African Med J. 1989;66:468-475.
20. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
21. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.